Latest / Walker Crips' Market Commentary

BoE Governor: Inflation taking longer than hoped to come down
Smith & Nephew, the British multinational medical equipment manufacturer, saw its share price increase by approximately 5% last week. The increase in share price was triggered as a result of Smith & Nephew receiving Food and Drug Administration ("FDA") clearance for its AETOS Shoulder System. This is the latest solution in Smith & Nephew’s expanding Upper Extremity portfolio and is designed to maximise stability, preserve bone and maintain patient anatomy. The company also noted that total shoulder arthroplasty is one of the fastest growing segments in Orthopaedics with an estimated 250,000…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.